Affiliation:
1. Division of Cardiology, Pauley Heart Center Virginia Commonwealth University Richmond VA USA
2. Faculty of Medicine St. George University of London London United Kingdom
3. University of Nicosia Medical School University of Nicosia Cyprus
4. Department of Cardiology The First Affiliated Hospital of Shantou University Medical College Shantou Guangdong China
5. Department of Mathematical Sciences Worcester Polytechnic Institute Worcester MA USA
6. Division of Cardiology, Department of Medicine University of Texas San Antonio San Antonio TX USA
7. Department of Hospital Internal Medicine Mayo Clinic Health System Mankato MN USA
8. Department of Medicine Eastern Carolina University Health Medical Center Greenville NC USA
9. Wafic Said Molecular Cardiology Research Laboratory The Texas Heart Institute Houston TX USA
10. Clinical Research Center The First Affiliated Hospital of Shantou University Medical College Shantou Guangdong China
Abstract
Background
Acute pericarditis (AP) is considered a cardiovascular complication in patients with COVID‐19. We aimed to ass‐ess the incidence, associated complications, and clinical impact of AP on hospitalized patients with COVID‐19.
Methods and Results
In this retrospective cohort study,
International Classification of Diseases, Tenthth Revision, Clinical Modification
(
ICD‐10
) codes were used to identify patients with COVID‐19 with or without AP in the National Inpatient Sample 2020 database. We compared outcomes between AP and non‐AP groups before and after propensity‐score matching for patient and hospital demographics and relevant comorbidities. A total of 211 619 patients with a primary diagnosis of COVID‐19 were identified, including 983 (0.46%) patients who had a secondary diagnosis of AP. Before matching, patients with COVID‐19 with AP were younger (59.93±19.24 years old versus 64.29±16.82 years old) and more likely to have anemia (40.5% versus 19.9%), cancer (6.7% versus 3.6%), and chronic kidney disease (29.3% versus 19.6%) (all
P
<0.05). After matching, patients with COVID‐19 with AP (n=980), when compared with the matched non‐AP group (n=2936), had higher rates of mortality (21.3% versus 11.1%,
P
<0.001), cardiac arrest (5.0% versus 2.6%,
P
<0.001), cardiogenic shock (4.2% versus 0.5%,
P
<0.001), ventricular arrhythmia (4.7% versus 1.9%,
P
<0.001), acute kidney injury (38.3% versus 28.9%,
P
<0.001), acute congestive heart failure (14.3% versus 4.8%,
P
<0.001), and longer length of stay (7.00±10.00 days versus 5.00±7.00 days,
P
<0.001) and higher total charges ($75066.5±$130831.3 versus $44824.0±$63660.5,
P
<0.001).
Conclusions
In hospitalized patients with COVID‐19, AP is a rare but severe in‐hospital complication and is associated with worse in‐hospital outcomes.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Cardiology and Cardiovascular Medicine
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献